IL6 and lung carcinoma: Further studies based on mouse lung cancer models and human cancer cell lines demonstrated that TBK1 signaling-regulated CCL 5 and IL-6 promote KRAS-driven NSCLC by affecting lung cancer cell proliferation and the local inflammatory microenvironment [123,124,125].